SCHEMBL8798665

SCHEMBL8798665

CCCc1nc(NC2CC2)nc(N2CCOCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.46
LMNA P02545 1/20 0.46
HPGD P15428 1/20 0.46
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.42
PIK3CA P42336 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
EHMT2 Q96KQ7 1/20 0.41
EHMT1 Q9H9B1 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
HSD17B10 Q99714 1/20 0.40
PIK3CB P42338 1/20 0.40
MAPT P10636 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9619171 0.83 SMN1; SMN2 (0.57) LMNAMEN1ALDH1A1KMT2AGAA
Hydrochloric Acid SCHEMBL10418857 0.82 SMN1; SMN2 (0.56) LMNAMEN1ALDH1A1KMT2AGAA
SCHEMBL9619145 0.82 GAA (0.50) LMNAMEN1ALDH1A1KMT2AGAA
SCHEMBL9619085 0.80 ALDH1A1 (0.46) LMNAMEN1ALDH1A1KMT2AGAA
SCHEMBL9619146 0.78 KDM4E (0.55) LMNAMEN1ALDH1A1KMT2AGAA
SCHEMBL3365592 0.78 CYP1A2 (0.56) LMNAMEN1ALDH1A1KMT2AGAA
SCHEMBL9619063 0.78 KDM4E (0.52) MEN1ALDH1A1KMT2AGAAKDM4E
SCHEMBL11520095 0.77 LMNA (0.51) NPSR1LMNAHPGDGAAPIK3CA
SCHEMBL9619183 0.76 KDM4E (0.50) LMNAMEN1ALDH1A1KMT2AGAA
SCHEMBL9619057 0.76 KDM4E (0.50) LMNAMEN1ALDH1A1KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527117-B1 Substituted cyclopropylamino-1,3,5-triazines UCB SA (BE) 1997-10-29 EP claimed
US-5348956-A Antiinflammatory and antiasthmatic agents UCB S.A. (BE) 1994-09-20 US claimed
US-5258513-A FOR TREATMENT OF ALZHEIMER'S DISEASE, SENILE DEMENTIA, EVOLUTIVE COGNITIVE PATHOLOGIES, DEPRESSION, ANXIETY, MOOD DISTURBANCES, INFLAMMATION AND ASTHMA UCB S.A. (BE) 1993-11-02 US claimed
EP-0527117-A1 Substituted cyclopropylamino-1,3,5-triazines U C B, S.A. (BE) 1993-02-10 EP claimed
JP-6220026-A None JP disclosed
EP-0527117-B1 Substituted cyclopropylamino-1,3,5-triazines UCB SA (BE) 1997-10-29 EP disclosed
US-5348956-A Antiinflammatory and antiasthmatic agents UCB S.A. (BE) 1994-09-20 US disclosed
JP-H06220026-A SUBSTITUTED CYCLOPROPYLAMINO-1,3,5-TRIAZINE COMPOUND UCB SA 1994-08-09 JP disclosed
US-5258513-A FOR TREATMENT OF ALZHEIMER'S DISEASE, SENILE DEMENTIA, EVOLUTIVE COGNITIVE PATHOLOGIES, DEPRESSION, ANXIETY, MOOD DISTURBANCES, INFLAMMATION AND ASTHMA UCB S.A. (BE) 1993-11-02 US disclosed
EP-0527117-A1 Substituted cyclopropylamino-1,3,5-triazines U C B, S.A. (BE) 1993-02-10 EP disclosed